Detalles de la búsqueda
1.
Population Pharmacokinetics and Adverse Events of Erlotinib in Japanese Patients with Non-small-cell Lung Cancer: Impact of Genetic Polymorphisms in Metabolizing Enzymes and Transporters.
Biol Pharm Bull
; 41(1): 47-56, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29311482
2.
Risk of CYP2C9 induction analyzed by a relative factor approach with human hepatocytes.
Drug Metab Pharmacokinet
; 34(5): 325-333, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31564409
3.
Phase I study of ipatasertib as a single agent and in combination with abiraterone plus prednisolone in Japanese patients with advanced solid tumors.
Cancer Chemother Pharmacol
; 84(2): 393-404, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31227862
4.
Simulating the Impact of Elevated Levels of Interleukin-6 on the Pharmacokinetics of Various CYP450 Substrates in Patients with Neuromyelitis Optica or Neuromyelitis Optica Spectrum Disorders in Different Ethnic Populations.
AAPS J
; 21(3): 42, 2019 03 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-30887238
Resultados
1 -
4
de 4
1
Próxima >
>>